Blood-Testing Company Theranos to Dissolve After Fraud Scandal
Firm will reportedly pay unsecured creditors with remaining cash in next few months.

Carlo Allegri/Reuters
The blood-testing company Theranos, once a rising star in Silicon Valley, will formally dissolve and pay unsecured creditors its remaining cash in the next few months, The Wall Street Journal reports. The announcement reportedly came in a shareholder email sent out Tuesday, weeks after the company’s former CEO and president were charged with “massive fraud” for allegedly duping investors out of hundreds of millions of dollars. Elizabeth Holmes, the former CEO and founder, was accused along with former President Ramesh Balwani of lying about the firm’s technological capabilities, as well as its financial status and connections to the Department of Defense. The company was also accused of giving health-care providers and patients “materially false and misleading information concerning the accuracy and reliability of Theranos’ blood-testing services.”
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
You're all set!
Thanks for subscribing.